Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000105

President and CEO sold 50,000 shares at $31.40 ($1,570,000)

  • President and CEO acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2023-06-16 Option exercise +50,000 $0.68 $34,000 2,289,913 I: show line 1 in the form
Watts Ryan J. President and CEO 2023-06-16 Sale −50,000 $31.40 $1,570,000 2,239,913 I: show line 2 in the form
Open-market sales · 50,000 sh · avg $31.40 · $1,570,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Watts Ryan J. President and CEO 2023-06-16 Option exercise · Stock Option (right to buy) −50,000 1,120,617 D: show line 3 in the form
Loading xslF345X04/wk-form4_1687300068.xml…